Clinical Trial Update: Ibrutinib as Neoadjuvant Therapy in Localized Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Ibrutinib as neoadjuvant therapy for localized prostate cancer has completed, with results posted. The study was conducted under Washin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Ibrutinib (ibrutinib)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2025-01-08